CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studies.

Siddiqui L, Hasan N, Mishra PK, Gupta N, Singh AT, Madaan A, Jaggi M, Saad S, Ekielski A, Iqbal Z, Kesharwani P, Talegaonkar S

Open source

DOI
10.1016/j.ijpharm.2023.123270
Published
2023 Aug 25
Container
International journal of pharmaceutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ijpharm.2023.123270,
  title = {CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studies.},
  author = {Siddiqui L and Hasan N and Mishra PK and Gupta N and Singh AT and Madaan A and Jaggi M and Saad S and Ekielski A and Iqbal Z and Kesharwani P and Talegaonkar S},
  year = {2023},
  journal = {International journal of pharmaceutics},
  doi = {10.1016/j.ijpharm.2023.123270},
  url = {https://doi.org/10.1016/j.ijpharm.2023.123270}
}

RIS

TY  - JOUR
TI  - CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studies.
AU  - Siddiqui L
AU  - Hasan N
AU  - Mishra PK
AU  - Gupta N
AU  - Singh AT
AU  - Madaan A
AU  - Jaggi M
AU  - Saad S
AU  - Ekielski A
AU  - Iqbal Z
AU  - Kesharwani P
AU  - Talegaonkar S
PY  - 2023
JO  - International journal of pharmaceutics
DO  - 10.1016/j.ijpharm.2023.123270
UR  - https://doi.org/10.1016/j.ijpharm.2023.123270
ER  - 

APA

L, S., N, H., PK, M., N, G., AT, S., A, M., M, J., S, S., A, E., Z, I., P, K., & S, T. (2023). CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studies.. International journal of pharmaceutics. https://doi.org/10.1016/j.ijpharm.2023.123270

Source records